SCHEMBL22739476

SCHEMBL22739476

c1ccc(N(c2ccc3cc4c(cc3c2)oc2cc3oc5cc6cc(N(c7ccccc7)c7cccc8c7ccc7ccccc78)ccc6cc5c3cc24)c2cccc3c2ccc2ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HPRT1 P00492 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ GPR55 Q9Y2T6 1/20 0.32
▸ HNF4A P41235 1/20 0.31
▸ XRCC6 P12956 1/20 0.30
▸ XRCC5 P13010 1/20 0.30
▸ PRKDC P78527 1/20 0.30
▸ SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22743219 0.96 KDM4E (0.35) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22742587 0.94 HPRT1 (0.36) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22740341 0.94 SIGMAR1 (0.35) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22740162 0.92 KDM4E (0.33) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22741420 0.92 KDM4E (0.33) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL23371104 0.91 SIGMAR1 (0.36) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22740283 0.90 HPRT1 (0.37) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22741277 0.90 SIGMAR1 (0.35) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL15851969 0.89 SIGMAR1 (0.35) KDM4EGLAHPGDHSD17B10MAPT
SCHEMBL22741871 0.89 PRKDC (0.33) KDM4EGLAHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, TMEM109, LEF1 KDM4E 3079/4885GLA 2730/4885HPGD 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback